Latest Blogs, Articles, and More
Learning to cope with a cancer diagnosis is an ongoing process. Coming face to face with death forces one to reexamine what is really important.
The Food and Drug Administration has approved Somatuline Depot (lanreotide) for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs), based on findings from the phase 3 CLARINET study.
Faslodex (fulvestrant) improved overall survival by nearly six months compared with anastrozole as initial hormone therapy for postmenopausal women with estrogen receptor-positive advanced breast cancer, according to findings from the phase 2 FIRST trial.
The FDA has approved Cyramza (ramucirumab) in combination with docetaxel for the treatment of patients with metastatic non-small cell lung cancer whose tumor has progressed during or following treatment with platinum-based chemotherapy.
Dr. Mary Claire King's search for the breast cancer gene spanned 20 years.